Earnings call transcript: Vital Farms beats Q2 2025 earnings expectations

Vital Farms (VITL) reported robust Q2 2025 results, significantly exceeding analyst expectations with EPS of $0.36 and revenue of $184.8 million, driving a 14.16% surge in pre-market trading. The company raised its full-year revenue guidance to at least $770 million and Adjusted EBITDA to at least $110 million, citing strong consumer demand and effective price increases. VITL is accelerating strategic investments, notably expanding its Seymour facility with two lines for $900 million revenue capacity by early 2027, increasing 2025 CapEx to $90M-$110M, positioning itself to capitalize on unmet demand and solidify its market leadership despite potential H2 tariff pressures and increased promotional activity.

Analysis

Vital Farms (VITL) delivered a significantly strong performance in Q2 2025, surpassing analyst expectations with an earnings per share of $0.36, a 33.33% beat over the $0.27 forecast. Revenue grew 25.4% year-over-year to $184.8 million, also exceeding forecasts, driven by a combination of volume growth and successful strategic pricing. The company's ability to implement price increases without eroding consumer demand underscores its strong brand loyalty and pricing power. In a pivotal strategic shift, management has raised its full-year revenue guidance to at least $770 million and is accelerating capital expenditures to $90-110 million for 2025, a substantial increase from the previous $50-60 million guidance. This accelerated investment is directed at building out two production lines simultaneously at its new Seymour, Indiana facility, aiming for a $900 million revenue capacity by early 2027. This move, funded by a strong balance sheet with $155 million in cash and no debt, signals management's confidence in capturing what it identifies as significant unmet consumer demand. While the outlook is robust, the company has flagged potential margin pressures in the second half of the year from U.S. tariffs and higher promotional spending, alongside an ongoing, though non-material, remediation of an internal control weakness.

Key Decisions for Investors

• Given the strong earnings beat, raised full-year guidance, and demonstrated pricing power, investors should view the company's accelerated capital expenditure plan as a confident move to address supply constraints and capture future growth.
• Investors should monitor the execution of the Seymour facility expansion, as its successful and timely completion is now central to the long-term growth thesis and achieving the projected $5 of annual revenue for every $1 of CapEx invested.
• It is prudent to watch for margin compression in the second half of 2025, as management has explicitly guided for headwinds from potential tariffs and increased promotional activity, which could impact profitability despite the strong revenue outlook.
• Considering the stock's 14.16% pre-market surge, investors should evaluate entry points in the context of analyst price targets of $41-$51 and the company's own assessment that it trades near fair value, weighing the positive operational momentum against valuation.